BOTH trivalent and quadrivalent influenza vaccines have again been recommended for the Australian 2017 influenza season.
The Australian Influenza Vaccine Committee (AIVC) met at TGA, Canberra, on 13 Oct 2016, to recommend influenza viruses to be used in the composition of the vaccines, ultimately recommending to the TGA that they adopt the Sep 2016 WHO recommendations.
The trivalent influenza vaccine components should contain the A (H1N1) strain: an A/Michigan/45/2015 (H1N1)pdm09 like virus, the A (H3N2) strain: an A/Hong Kong/4801/2014 (H3N2) like virus and the B strain: a B/Brisbane/60/2008 like virus.
The quadrivalent vaccine is to contain the trivalent influenza vaccine components as well as the additional B strain: a B/Phuket/3073/2013 like virus.
The AIVC recommendation for 2017 introduces a new A (H1N1)pdm09 like virus strain.
The above article was sent to subscribers in Pharmacy Daily's issue from 27 Oct 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Oct 16
